BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12975294)

  • 1. Spectrum of saccade system function in Alzheimer disease.
    Shafiq-Antonacci R; Maruff P; Masters C; Currie J
    Arch Neurol; 2003 Sep; 60(9):1272-8. PubMed ID: 12975294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.
    Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG
    Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory control of saccadic eye movements and cognitive impairment in Alzheimer's disease.
    Crawford TJ; Higham S; Renvoize T; Patel J; Dale M; Suriya A; Tetley S
    Biol Psychiatry; 2005 May; 57(9):1052-60. PubMed ID: 15860346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age on latency and error generation in internally mediated saccades.
    Abel LA; Douglas J
    Neurobiol Aging; 2007 Apr; 28(4):627-37. PubMed ID: 16540205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saccade deficits in amnestic mild cognitive impairment resemble mild Alzheimer's disease.
    Peltsch A; Hemraj A; Garcia A; Munoz DP
    Eur J Neurosci; 2014 Jun; 39(11):2000-13. PubMed ID: 24890471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonepisodic memory deficits in amnestic MCI.
    Economou A; Papageorgiou SG; Karageorgiou C; Vassilopoulos D
    Cogn Behav Neurol; 2007 Jun; 20(2):99-106. PubMed ID: 17558253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisaccade performance in patients with multiple sclerosis.
    Fielding J; Kilpatrick T; Millist L; White O
    Cortex; 2009; 45(7):900-3. PubMed ID: 19327763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficits in saccadic eye-movement control in Parkinson's disease.
    Chan F; Armstrong IT; Pari G; Riopelle RJ; Munoz DP
    Neuropsychologia; 2005; 43(5):784-96. PubMed ID: 15721191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
    Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K
    Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?
    van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J
    Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of calculation abilities in patients with mild and moderate Alzheimer disease.
    Martin RC; Annis SM; Darling LZ; Wadley V; Harrell L; Marson DC
    Arch Neurol; 2003 Nov; 60(11):1585-9. PubMed ID: 14623731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociating cognitive deficits involved in voluntary eye movement dysfunctions in Parkinson's disease patients.
    Amador SC; Hood AJ; Schiess MC; Izor R; Sereno AB
    Neuropsychologia; 2006; 44(8):1475-82. PubMed ID: 16376954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
    Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive measures predict pathologic Alzheimer disease.
    Powell MR; Smith GE; Knopman DS; Parisi JE; Boeve BF; Petersen RC; Ivnik RJ
    Arch Neurol; 2006 Jun; 63(6):865-8. PubMed ID: 16769868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
    Zetterberg H; Andreasson U; Hansson O; Wu G; Sankaranarayanan S; Andersson ME; Buchhave P; Londos E; Umek RM; Minthon L; Simon AJ; Blennow K
    Arch Neurol; 2008 Aug; 65(8):1102-7. PubMed ID: 18695061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Semantic Object Retrieval Test (SORT) in normal aging and Alzheimer disease.
    Kraut MA; Cherry B; Pitcock JA; Vestal L; Henderson VW; Hart J
    Cogn Behav Neurol; 2006 Dec; 19(4):177-84. PubMed ID: 17159612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.